Business

FDA accepts previously rejected application for new PET imaging agent

The radiopharma firm hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer.

U2Fx.comU2Fx.com
Apr 13, 2026 - 10:00
 0  2
FDA accepts previously rejected application for new PET imaging agent
The radiopharma firm hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer.
Read More

Tags:

Previous Article

China’s TCL Is Said to Consider Stake Sale in India TV Business

Next Article

Oil price tops $100 a barrel again after Trump announces strait of Hormuz blockade

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

Minneapolis businesses losing millions in sales each week as ICE operation continues

Minneapolis businesses losing millions in sales each we...

U2Fx.com Feb 6, 2026  0  8

After decades of cars and loyal customers, a Salt Lake City auto shop closes for the last time

After decades of cars and loyal customers, a Salt Lake ...

U2Fx.com Feb 7, 2026  0  13

Flagler Beach businesses push for trolley as pier project limits parking

Flagler Beach businesses push for trolley as pier proje...

U2Fx.com Nov 1, 2025  0  16